Literature DB >> 29607294

[18F]-choline PET/CT as an imaging biomarker for primary liver cancers.

Zhenghong Lee1.   

Abstract

Entities:  

Year:  2016        PMID： 29607294      PMCID： PMC5875439          DOI： 10.21037/tcr.2016.12.41

Source DB:  PubMed          Journal:  Transl Cancer Res        ISSN： 2218-676X            Impact factor:   1.241


× No keyword cloud information.
  19 in total

1.  [68Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECH.

Authors:  A Afshar-Oromieh; U Haberkorn; M Eder; M Eisenhut; C M Zechmann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-02-04       Impact factor: 9.236

2.  PET/CT in patients with hepatocellular carcinoma using [(18)F]fluorocholine: preliminary comparison with [(18)F]FDG PET/CT.

Authors:  Jean-Noël Talbot; Fabrice Gutman; Laetitia Fartoux; Jean-Didier Grange; Nathalie Ganne; Khaldoun Kerrou; Dany Grahek; Françoise Montravers; Raoul Poupon; Olivier Rosmorduc
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-06-27       Impact factor: 9.236

3.  Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer.

Authors:  T R DeGrado; R E Coleman; S Wang; S W Baldwin; M D Orr; C N Robertson; T J Polascik; D T Price
Journal:  Cancer Res       Date:  2001-01-01       Impact factor: 12.701

4.  Fluorocholine PET/CT in patients with prostate cancer: initial experience.

Authors:  Daniel T Schmid; Hubert John; Roland Zweifel; Tibor Cservenyak; Gerrit Westera; Gerhard W Goerres; Gustav K von Schulthess; Thomas F Hany
Journal:  Radiology       Date:  2005-05       Impact factor: 11.105

5.  [18F]Fluorocholine PET/CT Imaging of Liver Cancer: Radiopathologic Correlation with Tissue Phospholipid Profiling.

Authors:  Sandi A Kwee; Miles M Sato; Yu Kuang; Adrian Franke; Laurie Custer; Kyle Miyazaki; Linda L Wong
Journal:  Mol Imaging Biol       Date:  2017-06       Impact factor: 3.488

6.  Detection of hepatocellular carcinoma with PET/CT: a prospective comparison of 18F-fluorocholine and 18F-FDG in patients with cirrhosis or chronic liver disease.

Authors:  Jean-Noël Talbot; Laetitia Fartoux; Sona Balogova; Valérie Nataf; Khaldoun Kerrou; Fabrice Gutman; Virginie Huchet; David Ancel; Jean-Didier Grange; Olivier Rosmorduc
Journal:  J Nucl Med       Date:  2010-10-18       Impact factor: 10.057

7.  The binding and translocation steps in transport as related to substrate structure. A study of the choline carrier of erythrocytes.

Authors:  R Devés; R M Krupka
Journal:  Biochim Biophys Acta       Date:  1979-11-02

8.  PET imaging of hepatocellular carcinoma with 2-deoxy-2[18F]fluoro-D-glucose, 6-deoxy-6[18F] fluoro-D-glucose, [1-11C]-acetate and [N-methyl-11C]-choline.

Authors:  N Salem; Y Kuang; F Wang; G T Maclennan; Z Lee
Journal:  Q J Nucl Med Mol Imaging       Date:  2008-11-28       Impact factor: 2.346

9.  Kinetics of [(11)C]choline uptake in prostate cancer: a PET study.

Authors:  Eija Sutinen; Martti Nurmi; Anne Roivainen; Matti Varpula; Tuula Tolvanen; Pertti Lehikoinen; Heikki Minn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-11-20       Impact factor: 9.236

10.  Chronic Liver Disease and the Detection of Hepatocellular Carcinoma by [(18)F]fluorocholine PET/CT.

Authors:  Sandi A Kwee; Linda L Wong; Brenda Y Hernandez; Owen T M Chan; Miles M Sato; Naoky Tsai
Journal:  Diagnostics (Basel)       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.